4Mockenhaupt M,Schopf E.Epidemiology of drug-induced severe skin reactions[J].Semin Cntan Med Srug,1996,15:236-243.
5Wolkenstein P,Revuz J.Drug-induced severe skin reactions.Incidence,management and prevention[J].Drug Saf,1995,13:56-68.
6Yarbrongh DR.Treatment of toxic epidermal necrolysis in a burn center[J].JSC Med Assoc,1997,93:347-350.
二级参考文献5
1[2]Rieder MJ. In vivo and in vitro testing for adverse drug reactions[J].Pediatr Clin North Am, 1997, 44(1):93-111.
2[4]Rzany B, Mockenhaupt M, Baur S, et al. Epidemiology of erythema exsudativurn multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry[J].J Clin Epidemiol,1996,49(7):769-773.
3[5]Roujeau JC, Guillaume JC, Fabre JP, et al. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985[J].Arch Dermatol,1990,126(1):37-42.
4[6]Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, StevensJohnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients[J].Arch Dermatol,1990,126(1):43-47.
